Human Proteome Project launches in Sydney
23 September, 2010 by Tim DeanIt’s the Next Big Thing in understanding human biology and the natural successor to the Human Genome Project. It’s the Human Proteome Project (HPP), and it was launched this morning by some of the leading figures in proteomics to a room filled with Australian an international delegates attending the HUPO World Congress in Darling Harbour in Sydney.
Feature: Mitochondrial mysteries
20 September, 2010 by Staff WritersThey are diseases most people haven’t heard of: Kearns-Sayre syndrome; Leber’s hereditary optic neuropathy; Leigh syndrome or mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS).
Australian researchers find blindness genes
19 September, 2010 by Staff WritersStudies of twins conducted at the Queensland Institute of Medical Research (QIMR) has revealed a number of genes that appear to affect eyesight.
Feature: Quest for the human proteome
14 September, 2010 by Tim DeanMapping the human genome, and its 21,000-odd protein-coding genes, was a mammoth undertaking, requiring a 10 year, multi-billion dollar, collaborative effort by teams from across the globe. Yet the Human Genome Project (HGP) was only the beginning. In Sydney in September, at the Human Proteome Organisation (HUPO) Annual World Congress, the next great undertaking in uncovering the foundations of human biology will begin, with the official launch of the Human Proteome Project.
Search for asthma gene gets serious down under
08 September, 2010 by Staff WritersThe largest ever Australian study looking into the genetic causes of asthma is about to get under way.
Search for asthma gene gets serious down under
08 September, 2010 by Staff WritersThe largest ever Australian study looking into the genetic causes of asthma is about to get under way.
Feature: Proteomics power of pawpaw
07 September, 2010 by Kate McDonaldIt may sound like the spiel of a snake-oil salesman, but the story behind the development of a new Australian product derived from an extract of pawpaw (Carica papaya) designed to promote wound healing is a compelling one. The Australian company behind it, Phoenix Eagle, has developed a new product, OPAL A, that could revolutionise wound healing and wound care.
Researchers find migraine gene
03 September, 2010 by David BinningAn international group of researchers has identified what might be the first known genetic indicator for migraine risk.
Feature: Diagnosing Darwin
01 September, 2010 by Graeme O'NeillIn January last year, Dr John Hayman read a biography of Charles Darwin and became intrigued by Darwin’s almost lifelong battle with a chronic, relapsing illness. But now, Hayman, an Associate Professor in Monash University’s Department of Pathology, thinks he’s narrowed it down to a rare mitochondrial disorder inherited from his mother.
Feature: Next next generation sequencing
26 August, 2010 by Staff WritersIt took nearly two decades to go from the release of the first semi-automated genome sequencer in the mid-1980s to the launch of Roche's flagship 454 FLX next generation sequencer in 2005. The 454 is now one of three major players in the next gen market whose impact on the world of genomics cannot be underestimated. Just five years later we are poised to embrace the next generation of sequencing technology.
Genes linked to cholesterol and heart disease discovered
05 August, 2010 by Tim DeanCardiovascular disease (CVD) is the leading cause of death in Australia, with the National Health and Medical Research Council (NHMRC) estimating it costs Australia $5.9 billion in 2004-2005.
Generics to shrink allergic rhinitis market 20 percent by 2019: Datamonitor
05 August, 2010 by Staff WritersThe world market for treatments addressing allergic rhinitis will shrink by 20 percent to $US4 billion over the next 10 years as increasing numbers of generic products come to market, according to industry analysts Datamonitor.
Inside nature’s most efficient motor: the flagellar
02 August, 2010 by Tim DeanIt’s one of nature’s most impressive machines, yet it’s barely micrometres long. It’s a motor with 99 per cent efficiency that can rotate at up to 100,000 rpm, and switch directions faster than any device created by human ingenuity.
Illumina Genome Network launches for human genome sequencing community
30 July, 2010 by Staff WritersNext-generation genome sequencing technology company, Illumina, today launched the Illumina Genome Network, which is a global partnership to link researchers working in human genome sequencing projects.
Feature: Towards the $1000 genome
27 July, 2010 by Graeme O'NeillThe $1000 genome is no longer just a lofty aspiration. The next generation of massively parallel, benchtop sequencers could see it realised within two years.
